GEN Exclusives

More »

GEN News Highlights

More »
Apr 28, 2014

Sartorius Stedim Biotech Becomes Major Owner of AllPure Technologies

  • Sartorius Stedim Biotech signed a deal to acquire the majority stake in AllPure Technologies. The privately owned, New Oxford, PA-based company specializes in single-use components for biopharmaceutical applications.

    “AllPure further completes our portfolio with innovative products that help our customers develop and manufacture their pharmaceutical drugs safer and more efficiently,” said Reinhard Vogt, member of Sartorius’ executive board.

    “We are excited to leverage Sartorius Stedim’s impressive R&D capabilities so that we can accelerate the launch of new products from AllPure,” added Michael Zumbrum, president of AllPure. And SSB’s global reach and industry relationships grant access to considerably more customers, especially in Europe and Asia, which have tremendous potential for AllPure’s products.

    AllPure’s product portfolio includes the Takeone® aseptic sampling system and the Quickseal® aseptic tube sealing system.


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?